Press Release

Advocates, Researchers Honored at Research & Hope Awards

PhRMA September 11, 2014

Washington, D.C. (September 11, 2014) 

— The Pharmaceutical Research and Manufacturers of America (PhRMA) today announced the recipients of the 2014 Research & Hope Awards, honoring researchers and patient advocates for their role in advancing biopharmaceutical research and improving patients’ access to care. This year’s awardees were recognized for their role in the fight against HIV/AIDS, a devastating disease that has taken the lives of more than 36 million people worldwide.

PhRMA along with 22 patient and community health organizations honored the 2014 award winners at an annual awards dinner in Washington, DC last night, which also featured a conversation with President George W. Bush and a keynote address by Anthony Fauci, Director of the National Institute of Allergy and Infectious Diseases.

"I am grateful for the generosity of the American people and to those individuals and organizations who are leading the fight to combat HIV/AIDS," said President Bush, who spoke about his administration's efforts to combat HIV/AIDS around the world. "PEPFAR has stopped the AIDS pandemic from destroying the continent of Africa, and we must continue the momentum and build on its successes. The U.S. must lead this effort."

“Millions of patients are living longer, healthier lives thanks to the hard work and dedication of this year’s award winners,” said Ian Read, PhRMA’s Chairman of the Board of Directors and Chairman and CEO of Pfizer, Inc. “These individuals are distinguished members of the scientific and advocacy communities whose contributions have transformed the lives of patients impacted by HIV/AIDS.”

Multiple medical advancements have taken place since 1981, when the U.S. Centers for Disease Control and Prevention identified the first five cases of HIV/AIDS. Since anti-retroviral treatments (ART) were approved in 1995, HIV/AIDS-related deaths in the United States have dropped by 83 percent, resulting in a 32 percent decline in HIV/AIDS-related hospitalizations. These medicines are improving overall care for patients and are helping to prevent costs associated with treating the disease. According to a University of Chicago study, HIV/AIDS patients today live 15 years longer than in the 1980s.

“The tremendous progress that has been made over the years in HIV/AIDS research and care would not have been possible without the contributions made by this year’s award winners and the other men and women who have dedicated their lives to this important cause,” said PhRMA President and CEO John J. Castellani. “These individuals give us hope that we will someday be able to find a cure for this deadly disease.”

new report released by PhRMA found that there are currently 44 medicines and vaccines in the development pipeline, including 25 antivirals, 16 vaccines and three cell/gene therapies.

Recipients of the PhRMA 2014 Research & Hope Awards are:

The PhRMA Research & Hope Award for Academic Research

  • Raymond Schinazi, Ph.D., D.Sc., Emory University

Dr. Raymond Schinazi was honored for his pioneering work that led to the development of drugs that are the backbone of combination regimens used in the treatment of HIV-1 infection. For more information on his critical work, see the video and his biography.

The PhRMA Research & Hope Award for Biopharmaceutical Industry Research

  • Bristol-Myers Squibb Company Discovery Medicine, Virology Team

The Bristol-Myers Squibb Company Virology Team, led by Dr. Dennis Grasela, was recognized for its longstanding work to develop an innovative HIV-1 attachment inhibitor and bring forward a drug candidate that may allow the possibility of viral suppression for HIV patients. The full team includes Dr. George Hanna, Dr. John Kadow, Dr. Mark Krystal and Dr. Nick Meanwell. For more information on the team’s research, see the video and team biography.

The PhRMA Research & Hope Award for Excellence in Advocacy & Activism

  • Phill Wilson, Black AIDS Institute

Phill Wilson, founder and CEO of the Black AIDS Institute, received the award for his work in engaging and mobilizing Black institutions and individuals in efforts to confront HIV. For more information on his efforts, see the video and his biography.

The PhRMA Research & Hope Award for Community Champion

  • Kathie Hiers, AIDS Alabama

Kathie Hiers, CEO of AIDS Alabama and a member of the Presidential Advisory Council on HIV/AIDS, was honored for her ongoing efforts in helping people with HIV/AIDS live healthy, independent lives. For more information on her contributions, see the video and her biography.

The PhRMA Research & Hope Award for Visibility & Progress Award

  • Hydeia Loren Broadbent, HIV/AIDS Activist

Hydeia Loren Broadbent, a distinguished international public speaker and HIV/AIDS activist, was recognized for spreading the message of HIV/AIDS awareness and prevention since the age of six.  For more information on her achievements, see the video and her biography.

Recipients of the awards were selected by the Scientific Advisory Board of the PhRMA Foundation following an open nominations process.

PhRMA was joined by 22 health advocacy partners in recognizing the 2014 Research & Hope Awards honorees: Advocates for Youth, AIDS Alabama, The AIDS Institute (TAI), AIDS United, American Academy of HIV Medicine, Association of Nurses in AIDS Care, Black AIDS Institute, Caregiver Action Network (CAN), Community Access National Network (CANN), Forum for Collaborative HIV Research, Gay and Lesbian Medical Association (GLMA), Gay and Lesbian Victory Fund and Institute, HealthHIV, HIV Medicine Association, Human Rights Campaign Foundation, International Association of Providers of AIDS Care (IAPAC), National Alliance for Caregiving, National Gay and Lesbian Task Force, Project HOPE, Seed Global Health, Services & Advocacy for GLBT Elders (SAGE) and Whitman-Walker Health.

For more information on the 2014 Research & Hope Awards, including honoree biographies and videos, visit

To learn more about the more than 40 medicines and vaccines for HIV infection currently in development as well as innovation in the disease’s treatment, view our recent press release here.   

The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research and biotechnology companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. Since 2000, PhRMA member companies have invested approximately $550 billion in the search for new treatments and cures, including an estimated $51.1 billion in 2013 alone.

Find PhRMA Online:

For information on how innovative medicines save lives, visit

For information on the Partnership for Prescription Assistance, visit

For information on ensuring the flow of medicines during public health emergencies, visit